Rodolfo Bordoni
Hematology & Oncology · Atlanta, GANPI 1215915079
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $107,435 of the $159,186 with a category attached, or 67.5%. 17 manufacturers reported payments, led by AstraZeneca at 47.4% of the total. Reporting peaked in 2023 at $50,872 and has fallen 99.4% since, to $325 in 2024. Among hematology & oncology clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 136 payments — averaging $1170.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$75K
- Mirati Therapeutics, Inc.$30K
- Merck$13K
- Johnson & Johnson$12K
- Genentech USA, Inc.$8K
- Takeda Pharmaceuticals U.S.A., Inc.$7K
- plus $14K from 11 others
Across 397 payments — averaging $9723.46 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Deciphera Pharmaceuticals Inc.$2M
- E.r. Squibb & Sons, L.L.C.$402K
- Merck$387K
- Astellas Pharma Global Development$229K
- AstraZeneca$198K
- G1 Therapeutics, Inc.$188K
- plus $479K from 11 others
What the payments were for
- Consulting fees$37,15023%
- Speaking & faculty fees$107,43567%
- Travel & lodging$11,7137%
- Food & beverage$2,8142%
- Education$740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 61 | $75,443 |
| Mirati Therapeutics, Inc. | 16 | $29,910 |
| Merck | 19 | $12,789 |
| Johnson & Johnson(2 entities) | 13 | $12,230 |
| Genentech USA, Inc. | 6 | $7,949 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $6,566 |
| Sanofi | 2 | $3,725 |
| Bayer | 2 | $2,700 |
| Astrazeneca UK Limited | 2 | $2,000 |
| Morphosys, US Inc. | 1 | $1,770 |
| G1 Therapeutics, Inc. | 1 | $1,500 |
| Jazz Pharmaceuticals Inc. | 1 | $1,313 |
| Janssen Scientific Affairs, LLC | 1 | $1,010 |
| Amgen | 2 | $141 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $74 |
| Exelixis Inc. | 1 | $41 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$159,186 in reported general payments places this provider in the 95th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Atlanta
- Ticiana LealAtlanta$450K
- Ajay NookaAtlanta$222K
- Mehmet BilenAtlanta$150K
- Olatunji AleseAtlanta$137K
- Gina D AmatoAtlanta$97K
- Otis BrawleyAtlanta$89K
- Conor SteuerAtlanta$86K
- Fuad El RassiAtlanta$84K
- Jonathon CohenAtlanta$84K
- Ioana BontaAtlanta$71K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.